Title	Imaging (CT or MRI)
Number of patients screened	10
Number of patients enrolled	10
Number of patients evaluable for toxicity	10
Number of patients evaluated for efficacy	10
Evaluation method	RECIST 1.1
Response assessment, CR	0 (0%)
Response assessment, PR	3 (30%)
Response assessment, SD	6 (60%)
Response assessment, PD	1 (10%)
Median duration assessments	Every 6 weeks